(Q73665844)

English

Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation

scientific article published on 01 May 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Felix Sedlmayer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

K Wurstbauer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Deutschmann

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Kranzinger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Merz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Rahim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H D Kogelnik

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

333-341

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCL

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Target volume definition for three-dimensional conformal radiation therapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional radiation treatment planning study for patients with carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional conformal radiation therapy: a testable hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with three-dimensional treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical results of three-dimensional conformal irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation for non-small cell lung cancer using conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of radical radiotherapy with beam's eye view techniques for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-Dimensional Conformal Radiation Therapy In Bronchogenic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900021-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00021-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10760428%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73665844&oldid=2243686580"